par Azambuja, Evandro ;Dinh, Phuong ;Piccart-Gebhart, Martine
Référence Clinical advances in hematology & oncology, 5, 9, page (707-717)
Publication Publié, 2007-09
Article révisé par les pairs
Titre:
  • Trastuzumab for early breast cancer: current status and future directions.
Auteur:Azambuja, Evandro; Dinh, Phuong; Piccart-Gebhart, Martine
Informations sur la publication:Clinical advances in hematology & oncology, 5, 9, page (707-717)
Statut de publication:Publié, 2007-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- economics
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- economics
Breast Neoplasms -- mortality
Chemotherapy, Adjuvant
Clinical Trials as Topic
Female
Heart Diseases -- chemically induced
Humans
Neoplasm Recurrence, Local -- drug therapy
Neoplasm Recurrence, Local -- economics
Neoplasm Recurrence, Local -- mortality
Protein Structure, Tertiary
Receptor, erbB-2 -- antagonists & inhibitors
Survival Rate
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:1543-0790
info:pmid/17982412